Effectiveness of palivizumab in preventing respiratory syncytial virus infection in high-risk children

To date, there is no consensus regarding palivizumab prophylaxis for respiratory syncytial virus infection. The purpose of this study is to assess the effectiveness of palivizumab prophylaxis to prevent respiratory syncytial virus-related infection consultations and hospitalizations in high-risk chi...

Descripción completa

Detalles Bibliográficos
Autores principales: Viguria, Natividad, Navascués, Ana, Juanbeltz, Regina, Echeverría, Alberto, Ezpeleta, Carmen, Castilla, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115746/
https://www.ncbi.nlm.nih.gov/pubmed/33502928
http://dx.doi.org/10.1080/21645515.2020.1843336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115746/
https://www.ncbi.nlm.nih.gov/pubmed/33502928
http://dx.doi.org/10.1080/21645515.2020.1843336

Ejemplares similares